{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:29:09Z","timestamp":1794655749632,"version":"4.9.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,16]]},"abstract":"<jats:p>Restless leg syndrome (Restless legs syndrome, RLS) is a common neurological disorder. The pathogenesis of RLS remains unknown, and recent pathophysiological developments have shown the contribution of various genetic markers, neurotransmitter dysfunction, and iron deficiency to the disease, as well as other unidentified contributing mechanisms, particularly chronic renal dysfunction. RLS enhancement syndrome is frequently observed in patients with RLS who have received long-term dopamine agonist therapy, manifesting as a worsening of RLS symptoms, usually associated with an increase in the dose of dopamine agonist. Some patients with RLS can adequately control their symptoms with non-pharmacological measures such as massage and warm baths. First-line treatment options include iron supplementation for those with evidence of reduced iron stores, or gabapentin or pregabalin, as well as dopamine agonists, such as pramipexole. Second-line therapies include opioids such as tramadol. RLS seriously affects the quality of life of patients, and because its pathogenesis is unclear, more biological evidence and treatment methods need to be explored.<\/jats:p>","DOI":"10.1097\/md.0000000000032324","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T14:01:24Z","timestamp":1671717684000},"page":"e32324","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Exploration of restless legs syndrome under the new concept: A review"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1832-5220","authenticated-orcid":false,"given":"Zhao","family":"Liu","sequence":"first","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqian","family":"Guan","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province"},{"name":"Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Pan","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province"},{"name":"First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","article-title":"Restless legs syndrome: contemporary diagnosis and treatment","volume":"18","author":"Gossard","year":"2021","journal-title":"Neurotherapeutics"},{"key":"R2-20250504","first-page":"8","article-title":"Attention-deficit\/hyperactivity and obsessive-compulsive symptoms in adult patients with primary restless legs syndrome","volume":"1","author":"Mazurie","year":"2022","journal-title":"Appl Neuropsychol Adult"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10194-022-01409-9","article-title":"Genome-wide analysis identified novel susceptible genes of restless legs syndrome in migraineurs","volume":"23","author":"Jiang","year":"2022","journal-title":"J Headache Pain"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/ene.14582","article-title":"Socioeconomic impact of restless legs syndrome and inadequate restless legs syndrome management across European settings","volume":"28","author":"Trenkwalder","year":"2021","journal-title":"Eur J Neurol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-019-0965-4","article-title":"Update on restless legs syndrome: from mechanisms to treatment","volume":"19","author":"Gonzalez-Latapi","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858418791763","article-title":"New insights into the neurobiology of restless legs syndrome","volume":"25","author":"Ferr\u00e9","year":"2019","journal-title":"Neuroscientist"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.27573","article-title":"Safety of dopamine agonists for treating restless legs syndrome","volume":"34","author":"Weiss","year":"2019","journal-title":"Mov Disord"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.mayocp.2020.12.026","article-title":"The management of restless legs syndrome: an updated algorithm","volume":"96","author":"Silber","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R9-20250504","first-page":"zsz223","article-title":"Striatal histamine mechanism in the pathogenesis of restless legs syndrome","volume":"43","author":"Lai","year":"2020","journal-title":"Sleep"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"101218","DOI":"10.1016\/j.smrv.2019.101218","article-title":"Magnesium supplementation for the treatment of restless legs syndrome and periodic limb movement disorder: a systematic review","volume":"48","author":"Marshall","year":"2019","journal-title":"Sleep Med Rev"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"sz265","DOI":"10.1093\/sleep\/zsz265","article-title":"Genetic and epidemiological characterization of restless legs syndrome in Qu\u00e9bec","volume":"43","author":"Ak\u00e7imen","year":"2020","journal-title":"Sleep"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.smrv.2019.05.005","article-title":"Restless legs syndrome: clinical changes in nervous system excitability at the spinal cord level","volume":"47","author":"Dafkin","year":"2019","journal-title":"Sleep Med Rev"},{"key":"R13-20250504","first-page":"187","article-title":"Meta-analysis of single nucleotide polymorphisms in restless legs syndrome risk genes","volume":"31","author":"Wang","year":"2022","journal-title":"Chin J Behav Med Brain Sci"},{"key":"R14-20250504","first-page":"1187","article-title":"Research progress on single nucleotide polymorphisms of restless legs syndrome risk genes","volume":"54","author":"Wang","year":"2021","journal-title":"Chin J Neurol"},{"key":"R15-20250504","first-page":"497","article-title":"Clinical features and standardized treatment of restless legs syndrome","volume":"26","author":"Zhao","year":"2021","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1756286420941670","DOI":"10.1177\/1756286420941670","article-title":"Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis","volume":"13","author":"Kocar","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s42003-020-1105-z","article-title":"Transcriptome-wide association study for restless legs syndrome identifies new susceptibility genes","volume":"3","author":"Ak\u00e7imen","year":"2020","journal-title":"Commun Biol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"zsac018","DOI":"10.1093\/sleep\/zsac018","article-title":"The conundrum of the origin of restless legs syndrome","volume":"45","author":"Lin","year":"2022","journal-title":"Sleep"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/mds.28640","article-title":"Lack of causal effects or genetic correlation between restless legs syndrome and Parkinson\u2019s disease","volume":"36","author":"Estiar","year":"2021","journal-title":"Mov Disord"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2174\/1570159X19666201230150127","article-title":"Pharmacologic treatment of restless legs syndrome","volume":"19","author":"Lv","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neubiorev.2020.10.008","article-title":"Sensory symptoms in body-focused repetitive behaviors, restless legs syndrome, and Tourette syndrome: an overlap?","volume":"119","author":"Badenoch","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/ene.14577","article-title":"Functional connectivity and topology in patients with restless legs syndrome: a case-control resting-state functional magnetic resonance imaging study","volume":"28","author":"Tuovinen","year":"2021","journal-title":"Eur J Neurol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e12741","DOI":"10.1111\/jsr.12741","article-title":"Are serum ferritin and transferrin saturation risk markers for restless legs syndrome in young adults? Longitudinal and cross-sectional data from the Western Australian Pregnancy Cohort (Raine) Study","volume":"28","author":"Lammers","year":"2019","journal-title":"J Sleep Res"},{"key":"R24-20250504","first-page":"908","article-title":"Guidelines for the diagnosis and treatment of restless legs syndrome in China (2021 edition)","volume":"101","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.sleep.2019.02.022","article-title":"Serum C-reactive protein\/albumin ratio and restless legs syndrome","volume":"58","author":"Olgun Yazar","year":"2019","journal-title":"Sleep Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e13161","DOI":"10.1111\/jsr.13161","article-title":"Childhood restless legs syndrome: a longitudinal study of prevalence and familial aggregation","volume":"30","author":"Pennestri","year":"2021","journal-title":"J Sleep Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/00207454.2020.1737048","article-title":"Presynaptic inhibition in restless legs syndrome","volume":"131","author":"T\u00fcrkoglu","year":"2021","journal-title":"Int J Neurosci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.chest.2020.03.035","article-title":"Emerging concepts of the pathophysiology and adverse outcomes of restless legs syndrome","volume":"158","author":"Romero-Peralta","year":"2020","journal-title":"Chest"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.27482","article-title":"Association of mitochondrial iron deficiency and dysfunction with idiopathic restless legs syndrome","volume":"34","author":"Haschka","year":"2019","journal-title":"Mov Disord"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"e12896","DOI":"10.1111\/jsr.12896","article-title":"Peculiar lifespan changes of periodic leg movements during sleep in restless legs syndrome","volume":"29","author":"Ferri","year":"2020","journal-title":"J Sleep Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.sleep.2021.07.027","article-title":"Correlation between systemic iron parameters and substantia nigra iron stores in restless legs syndrome","volume":"85","author":"Garcia-Malo","year":"2021","journal-title":"Sleep Med"},{"key":"R32-20250504","first-page":"994","article-title":"Progress in diagnosis and treatment of restless legs syndrome","author":"Caixia","year":"2019","journal-title":"Chin J Gen Pract"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00429-020-02090-x","article-title":"BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome","volume":"225","author":"Lyu","year":"2020","journal-title":"Brain Struct Funct"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/mds.28401","article-title":"Consensus guidelines on rodent models of restless legs syndrome","volume":"36","author":"Salminen","year":"2021","journal-title":"Mov Disord"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.sleep.2020.09.002","article-title":"Bioinformatic analysis of proteomic data for iron, inflammation, and hypoxic pathways in restless legs syndrome","volume":"75","author":"Shin","year":"2020","journal-title":"Sleep Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"zsz079","DOI":"10.1093\/sleep\/zsz079","article-title":"Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome","volume":"42","author":"Chawla","year":"2019","journal-title":"Sleep"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"134494","DOI":"10.1016\/j.neulet.2019.134494","article-title":"Thalamic GABA may modulate cognitive control in restless legs syndrome","volume":"712","author":"Zhang","year":"2019","journal-title":"Neurosci Lett"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"zsz027","DOI":"10.1093\/sleep\/zsz027","article-title":"Restless legs syndrome and iron deficiency in adults with attention-deficit\/hyperactivity disorder","volume":"42","author":"Lopez","year":"2019","journal-title":"Sleep"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.sleep.2018.11.011","article-title":"Decline in dopamine agonists prescribing and characteristics of drugs prescribed during ambulatory office visits for restless legs syndrome: the national ambulatory medical care survey 2007-2015","volume":"54","author":"Kim","year":"2019","journal-title":"Sleep Med"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2019.02.009","article-title":"Iron supplementation for restless legs syndrome\u2014a systematic review and meta-analysis","volume":"63","author":"Avni","year":"2019","journal-title":"Eur J Intern Med"},{"key":"R41-20250504","article-title":"The impact of subthalamic deep brain stimulation on restless legs syndrome in Parkinson\u2019s disease","author":"Dulski","year":"2021","journal-title":"Neuromodulation"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.sleep.2009.01.006","article-title":"The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/WNL.0000000000007412","article-title":"Author response: deep brain stimulation improves restless legs syndrome in patients with Parkinson disease","volume":"92","author":"Klepitskaya","year":"2019","journal-title":"Neurology"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1212\/WNL.0000000000007500","article-title":"Association between restless legs syndrome and other movement disorders","volume":"92","author":"Alonso-Navarro","year":"2019","journal-title":"Neurology"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.25658","article-title":"Identification of restless legs syndrome genes by mutational load analysis","volume":"87","author":"Tilch","year":"2020","journal-title":"Ann Neurol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/jnr.24637","article-title":"Mu opioid receptor knockout mouse: phenotypes with implications on restless legs syndrome","volume":"98","author":"Lyu","year":"2020","journal-title":"J Neurosci Res"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"e13298","DOI":"10.1111\/jsr.13298","article-title":"Grey matter alterations in restless legs syndrome: a coordinate-based meta-analysis","volume":"30","author":"Sheng","year":"2021","journal-title":"J Sleep Res"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/mds.28668","article-title":"A randomized, placebo-controlled crossover study with Dipyridamole for restless legs syndrome","volume":"36","author":"Garcia-Borreguero","year":"2021","journal-title":"Mov Disord"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.5664\/jcsm.9404","article-title":"Noninvasive neuromodulation reduces symptoms of restless legs syndrome","volume":"17","author":"Buchfuhrer","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.sleep.2020.07.011","article-title":"Cognitive behavioral therapy for insomnia in restless legs syndrome patients","volume":"74","author":"Song","year":"2020","journal-title":"Sleep Med"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5664\/jcsm.8134","article-title":"Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial","volume":"16","author":"Innes","year":"2020","journal-title":"J Clin Sleep Med"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sleep.2020.06.003","article-title":"Restless legs syndrome masquerades as chronic insomnia","volume":"75","author":"Bonakis","year":"2020","journal-title":"Sleep Med"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.mayocp.2013.06.016","article-title":"Willis-Ekbom disease foundation revised consensus statement on the management of restless legs syndrome","volume":"88","author":"Silber","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sleep.2020.06.002","article-title":"Low risk of iron overload or anaphylaxis during treatment of restless legs syndrome with intravenous iron: a consecutive case series in a regular clinical setting","volume":"74","author":"Garcia-Malo","year":"2020","journal-title":"Sleep Med"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The longterm treatment of restless legs syndrome\/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the international restless legs syndrome study group","volume":"14","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep Med"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.sleep.2018.11.025","article-title":"Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment","volume":"55","author":"Garcia-Borreguero","year":"2019","journal-title":"Sleep Med"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41572-021-00311-z","article-title":"Restless legs syndrome","volume":"7","author":"Manconi","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the frst-line treatment of restless legs syndrome\/WillisEkbom disease, prevention and treatment of dopaminergic augmentation:a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00415-019-09682-6","article-title":"Restless legs syndrome: causes and consequences","volume":"267","author":"Massey","year":"2020","journal-title":"J Neurol"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"zsab212","DOI":"10.1093\/sleep\/zsab212","article-title":"High national rates of high-dose dopamine agonist prescribing for restless legs syndrome","volume":"45","author":"Winkelman","year":"2022","journal-title":"Sleep"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/mds.28903","article-title":"Depressive symptoms and suicidal thoughts in restless legs syndrome","volume":"7","author":"Chenini","year":"2022","journal-title":"Mov Disord"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.5664\/jcsm.7908","article-title":"Increased risk for new-onset psychiatric adverse events in patients with newly diagnosed primary restless legs syndrome who initiate treatment with dopamine agonists: a large-scale retrospective claims matched-cohort analysis","volume":"15","author":"Hankin","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.13184","article-title":"Successful discontinuation of oxycodone under pramipexole treatment for restless legs syndrome due to withdrawal","volume":"75","author":"Sakurai","year":"2021","journal-title":"Psychiatry Clin Neurosci"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/mds.28224","article-title":"Increased blood pressure dipping in restless legs syndrome with Rotigotine: a randomized trial","volume":"35","author":"Chenini","year":"2020","journal-title":"Mov Disord"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"751643","DOI":"10.3389\/fnins.2021.751643","article-title":"The efficacy and safety of pharmacological treatments for restless legs syndrome: systemic review and network meta-analysis","volume":"15","author":"Zhou","year":"2021","journal-title":"Front Neurosci"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"16344","DOI":"10.1038\/s41598-019-52735-z","article-title":"Rotigotine suppresses sleep-related muscle activity augmented by injection of dialysis patients\u2019 sera in a mouse model of restless legs syndrome","volume":"9","author":"Muramatsu","year":"2019","journal-title":"Sci Rep"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.sleep.2022.01.011","article-title":"Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic","volume":"90","author":"Wipper","year":"2022","journal-title":"Sleep Med"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"e13216","DOI":"10.1111\/jsr.13216","article-title":"PTPRD as a candidate druggable target for therapies for restless legs syndrome?","volume":"30","author":"Morais","year":"2021","journal-title":"J Sleep Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:16:21Z","timestamp":1746332181000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":68,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032324","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}